Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Using Ultrasound to Treat Brain Tumors

By HospiMedica staff writers
Posted on 27 Jul 2005
Researchers are studying the feasibility of using high-intensity focused ultrasound (HIFU) as a noninvasive way to treat brain tumors.

HIFU generates ultrasonic waves at an intensity several orders of magnitude higher than those utilized in medical imaging. More...
The waves are focused much in the same manner as those used in medical imaging. HIFU can be made to accurately kill cells by producing heat, but it can do so without killing cells outside the focused area.

"You want to ‘cook' only the tumor and not the surrounding cells,” said Dr. Viren Amin, leader of the study and a scientist at the Center for Nondestructive Evaluation at Iowa State University (Ames, IA, USA) and an adjunct professor of electrical and computer engineering.

There are obstacles to overcome before the ultrasound technology can be used to destroy brain tumors. "We need to predict what the ultrasound beam will do when it goes through so many layers of tissue,” said Dr. Amin. This tissue "inhomogeniety” causes ultrasound energy to be localized in hot spots. The researchers have devised computational models for ultrasound transmission through inhomogeneous materials. Dr. Amin reported that these data can be applied to medical applications to develop high-precision ultrasound therapy.

Another challenge is calculating and delivering the therapy dose--the frequency, intensity, and focus--for a certain type of tumor and location. The scientists will develop visualization and imaging tools to incorporate magnetic resonance imaging (MRI) and ultrasound images as well as simulations of ultrasound beams through tissues and of the heat generated at the focus. These tools will be used to aid in planning high-intensity focused ultrasound treatments. "It's a true multidisciplinary project,” said Dr. Amin.




Related Links:
Iowa State University

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.